123 related articles for article (PubMed ID: 3820601)
1. [Basic evaluation of measurement of the serum level of squamous cell carcinoma-related antigen (SCC) and its value following irradiation of cancer of the uterine cervix].
Obata Y; Tadokoro M; Kazato S; Nishi H; Ito M; Shibata H; Mizuno K; Kawamura N; Yamaguchi T; Yoshizumi T
Gan No Rinsho; 1987 Jan; 33(1):60-4. PubMed ID: 3820601
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC].
Fukunaga M; Otsuka N; Sone T; Nagai K; Muranaka A; Furukawa T; Yanagi M; Yanagimoto S; Tomomitsu T; Morita R
Gan No Rinsho; 1985 Dec; 31(15):1885-8. PubMed ID: 3842935
[TBL] [Abstract][Full Text] [Related]
3. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
Ohno T; Nakayama Y; Nakamoto S; Kato S; Imai R; Nonaka T; Ishikawa H; Harashima K; Suzuki Y
Cancer; 2003 Jun; 97(12):3114-20. PubMed ID: 12784349
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
5. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
7. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
Micke O; Prott FJ; Schäfer U; Tangerding S; Pötter R; Willich N
Anticancer Res; 2000; 20(6D):5113-5. PubMed ID: 11326679
[TBL] [Abstract][Full Text] [Related]
8. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of serum squamous cell carcinoma-related antigen levels in penile cancer].
Takahashi Y; Horie M; Isogai K; Takeuchi T; Shinoda I; Kuriyama M; Ban Y
Hinyokika Kiyo; 1987 Mar; 33(3):396-9. PubMed ID: 3618407
[TBL] [Abstract][Full Text] [Related]
10. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM
Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
13. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
Chan YM; Ng TY; Ngan HY; Wong LC
Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
Forni F; Ferrandina G; Deodato F; Macchia G; Morganti AG; Smaniotto D; Luzi S; D'Agostino G; Valentini V; Cellini N; Giardina B; Scambia G
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1145-9. PubMed ID: 17689030
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
[TBL] [Abstract][Full Text] [Related]
20. Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurements.
Lozza L; Merola M; Fontanelli R; Stefanon B; Seregni E; Bombardieri E; De Palo G
Anticancer Res; 1997; 17(1B):525-9. PubMed ID: 9066575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
